A BOTANICAL STORY FROM NANTES · DOCUMENTARY EDITION
tosma✳
UNDERSTAND · CHOOSE · MOVE FORWARD

Vaping and quitting: read the findings and their limits.

Trials of smoking cessation and questions about long-term safety measure different things. Evidence of effectiveness does not mean absence of risk.

Separate the outcome from the product.

A cessation study may measure cigarette abstinence after several months. That does not establish that participants stopped all nicotine or that a product is harmless over decades. These outcomes must be read separately.

Vaping produces an aerosol and should not be confused with a patch or a herbal cigarette. Devices, liquids and patterns of use vary, so a trial result does not validate every commercial product. This article discusses evidence rather than recommending equipment.

Four questions for reading trials.. Population: Adults who smoked. Comparison: Nicotine vaping and other aids. Outcome: Cigarette abstinence at 6+ months. Limit: Long-term safety is separate
This diagram explains how to read evidence; it does not recommend a device.

What to look for in a study.

Before using a figure, ask what was compared and for how long. A personal account, a few days of observation and a randomised trial with six-month follow-up provide different types of information. The study population matters as much as its headline.

QuestionWhat it measuresWhat it does not establish
Quitting at six months or moreCigarette abstinence under a study protocolLifetime freedom from nicotine
Comparison with NRTRelative outcomes within the trialsSuperiority of every device
Reported unwanted effectsEvents recorded during follow-upAbsence of all future risk
Continued cigarette useA different situation from complete switchingThe same benefit as stopping cigarettes
Evidence in adults who smokeThe studied populationA reason for a non-smoker to start

The 2026 living Cochrane review.

The 2026 update by Lindson and colleagues finds high-certainty evidence of higher quit rates with nicotine e-cigarettes than with NRT in the compared trials. Evidence about unwanted effects remains less certain, particularly regarding long-term consequences.

The finding concerns cessation support for people who smoke. It is not a reason for a non-smoker to start vaping and should not be translated into a claim that vaping is harmless.

Prepare a discussion, not a purchase here.

If you want to discuss this option, first state the question: stopping cigarettes, understanding simultaneous use or reviewing a stalled attempt. Describe the products you already use. This page provides no brand selection, liquid dose or buying recommendation.

Ask how actual cigarette cessation would be assessed and how other support fits into the plan. General trial findings should not be transferred to pregnancy, breastfeeding or people under 18 without tailored advice. These circumstances call for an appropriate professional assessment.

Useful questions

Is vaping risk-free?

No. A possible relative benefit compared with continued smoking does not mean absence of risk.

Do the results apply to non-smokers?

No. A cessation trial is not a reason to start using nicotine when you do not smoke.

General information for adults, not a substitute for medical advice. Treatment selection, dose and duration should be agreed with a healthcare professional. Pregnancy, breastfeeding, age under 18 or significant illness require tailored support.